Rise and dissemination of aminoglycoside resistance: The aac(6′)-Ib paradigm

Frontiers in Microbiology

Volumn 4, Issue MAY, 2013, Pages

  Ramirez, María S ^a   Nikolaidis, Nikolas ^a   Tolmasky, Marcelo E ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Acetyltransferase; Aminoglycoside; Antibiotic resistance; Inhibition; Integron; Mobile elements; Transposon

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IB; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IIA; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IIB; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IIC; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IID; ANTISENSE OLIGONUCLEOTIDE; CIPROFLOXACIN; COENZYME A; GENTAMICIN; KANAMYCIN; MESSENGER RNA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ACETYLATION; ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE GENE; AMINOGLYCOSIDE RESISTANCE; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; ELECTROPORATION; ENTEROBACTER; ENTEROCOCCUS FAECIUM; GENE EXPRESSION; HEAT SENSITIVITY; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; REVIEW; SALMONELLA TYPHIMURIUM; SEQUENCE HOMOLOGY; SIMULATION; STAPHYLOCOCCUS AUREUS; TRANSPOSON;

NEGIBACTERIA;

EID: 84884236711     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00121     Document Type: Review

References (136)

1. Avent, M. L., Rogers, B. A., Cheng, A. C., and Paterson, D. L. (2011). Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern. Med. J. 41, 441-449.
2. Bakker, E. P. (1992). Aminoglycoside and aminocyclitol antibiotics: hygromycin B is an atypical bactericidal compound that exerts effects on cells of Escherichia coli characteristics for bacteriostatic aminocyclitols. J. Gen. Microbiol. 138, 563-569.
3. Belousoff, M. J., Graham, B., Spiccia, L., and Tor, Y. (2009). Cleavage of RNA oligonucleotides by aminoglycosides. Org. Biomol. Chem. 7, 30-33.
4. Bidou, L., Allamand, V., Rousset, J. P., and Namy, O. (2012). Sense from nonsense: therapies for premature stop codon diseases. Trends Mol. Med. 18, 679-688.
5. Boehr, D. D., Draker, K. A., Koteva, K., Bains, M., Hancock, R. E., and Wright, G. D. (2003). Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. Chem. Biol. 10, 189-196.
6. Bonnin, R. A., Poirel, L., Carattoli, A., and Nordmann, P. (2012). Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS ONE 7:e34752. doi: 10.1371/journal.pone.0034752
7. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1-12.
8. Brossier, F., Veziris, N., Aubry, A., Jarlier, V., and Sougakoff, W. (2010). Detection by Geno-type MTBDRsl test of complex resistance mechanisms to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48, 1683-1689.
9. Bryskier, A. (2005). "Antibiotics and antibacterial agents: classifications and structure-activity relationships," in Antimicrobial Agents, ed A. Bryskier (Washington, DC: ASM Press), 13-38.
10. Burk, D. L., and Berghuis, A. M. (2002). Protein kinase inhibitors and antibiotic resistance. Pharmacol. Ther. 93, 283-292.
11. Busse, H. J., Wostmann, C., and Bakker, E. P. (1992). The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins. J. Gen. Microbiol. 138, 551-561.
12. Cambray, G., Guerout, A. M., and Mazel, D. (2010). Integrons. Annu. Rev. Genet. 44, 141-166.
13. Cambray, G., and Mazel, D. (2008). Synonymous genes explore different evolutionary landscapes. PLoS Genet. 4:e1000256. doi: 10.1371/journal.pgen.1000256
14. Casin, I., Bordon, F., Bertin, P., Coutrot, A., Podglajen, I., Brasseur, R., et al. (1998). Aminoglycoside 6β-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob. Agents Chemother. 42, 209-215.
15. Casin, I., Hanau-Bercot, B., Podglajen, I., Vahaboglu, H., and Collatz, E. (2003). Salmonella enterica serovar Typhimurium bla(PER-1)-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6β-N-acetyltransferase of type Ib. Antimicrob. Agents Chemother. 47, 697-703.
16. Cattoir, V., and Nordmann, P. (2009). Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr. Med. Chem. 16, 1028-1046.
17. Chavideh, R., Sholly, S., Panaite, D., and Tolmasky, M. E. (1999). Effects of F171 mutations in the 6β-N-acetyltransferase type Ib [AAC(6β)-Ib] enzyme on susceptibility to aminoglycosides. Antimicrob. Agents Chemother. 43, 2811-2812.
18. Chen, L., Chavda, K. D., Mediavilla, J. R., Zhao, Y., Fraimow, H. S., Jenkins, S. G., et al. (2012). Multiplex real-time PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone. Antimicrob. Agents Chemother. 56, 3444-3447.
19. Chen, W., Biswas, T., Porter, V. R., Tsodikov, O. V., and Garneau-Tsodikova, S. (2011). Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB. Proc. Natl. Acad. Sci. U.S.A. 108, 9804-9808.
20. Chiang, W. C., Nilsson, M., Jensen, P. O., Hoiby, N., Nielsen, T. E., Givskov, M., et al. (2013). Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 57, 2352-2361.
21. Daigle, D. M., McKay, G. A., and Wright, G. D. (1997). Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors. J. Biol. Chem. 272, 24755-24758.
22. De Pascale, G., and Wright, G. D. (2010). Antibiotic resistance by enzyme inactivation: from mechanisms to solutions. Chembiochem 11, 1325-1334.
23. Dery, K. J., Chavideh, R., Waters, V., Chamorro, R., Tolmasky, L. S., and Tolmasky, M. E. (1997). Characterization of the replication and mobilization regions of the multiresistance Klebsiella pneumoniae plasmid pJHCMW1. Plasmid 38, 97-105.
24. Dery, K. J., Soballe, B., Witherspoon, M. S., Bui, D., Koch, R., Sherratt, D. J., et al. (2003). The aminoglycoside 6β-N-acetyltransferase type Ib encoded by Tn1331 is evenly distributed within the cell's cytoplasm. Antimicrob. Agents Chemother. 47, 2897-2902.
25. De Toro, M., Rodriguez, I., Rojo-Bezares, B., Helmuth, R., Torres, C., Guerra, B., et al. (2013). pMdT1, a small ColE1-like plasmid mobilizing a new variant of the aac (6β)-Ib-cr gene in Salmonella enterica serovar Typhimurium. J. Antimicrob. Chemother. doi: 10.1093/jac/dkt001. [Epub ahead of print].
26. Draker, K. A., Northrop, D. B., and Wright, G. D. (2003). Kinetic mechanism of the GCN5-related chromosomal aminoglycoside acetyltransferase AAC(6β)-Ii from Enterococcus faecium: evidence of dimer subunit cooperativity. Biochemistry 42, 6565-6574.
27. Drawz, S. M., and Bonomo, R. A. (2010). Three decades of beta-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160-201.
28. Dubois, V., Poirel, L., Marie, C., Arpin, C., Nordmann, P., and Quentin, C. (2002). Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6β-Ibβ gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46, 638-645.
29. Dyda, F., Klein, D. C., and Hickman, A. B. (2000). GCN5-related N-acetyltransferases: a structural overview. Annu. Rev. Biophys. Biomol. Struct. 29, 81-103.
30. Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., et al. (2009). ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrob. Agents Chemother. 53, 4504-4507.
31. Galani, I., Xirouchaki, E., Kanellakopoulou, K., Petrikkos, G., and Giamarellou, H. (2002). Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. Clin. Microbiol. Infect. 8, 579-588.
32. Gao, F., Yan, X., Baettig, O. M., Berghuis, A. M., and Auclair, K. (2005). Regio-and chemoselective 6β-N-derivatization of aminoglycosides: bisubstrate inhibitors as probes to study aminoglycoside 6β-N-acetyltransferases. Angew. Chem. Int. Ed. Engl. 44, 6859-6862.
33. Gao, F., Yan, X., Shakya, T., Baettig, O. M., Ait-Mohand-Brunet, S., Berghuis, A. M., et al. (2006). Synthesis and structure-activity relationships of truncated bisubstrate inhibitors of aminoglycoside 6β-N-acetyltransferases. J. Med. Chem. 49, 5273-5281.
34. Garcia-Fernandez, A., Villa, L., Carta, C., Venditti, C., Giordano, A., Venditti, M., et al. (2012). Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob. Agents Chemother. 56, 2143-2145.
35. Green, K. D., Chen, W., and Garneau-Tsodikova, S. (2011). Effects of altering aminoglycoside structures on bacterial resistance enzyme activities. Antimicrob. Agents Chemother. 55, 3207-3213.
36. Green, K. D., Chen, W., and Garneau-Tsodikova, S. (2012). Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis. ChemMedChem 7, 73-77.
37. Green, K. D., Chen, W., Houghton, J. L., Fridman, M., and Garneau-Tsodikova, S. (2010). Exploring the substrate promiscuity of drug-modifying enzymes for the chemoenzymatic generation of N-acylated aminoglycosides. Chembiochem 11, 119-126.
38. Guerrier-Takada, C., Salavati, R., and Altman, S. (1997). Phenotypic conversion of drug-resistant bacteria to drug sensitivity. Proc. Natl. Acad. Sci. U.S.A. 94, 8468-8472.
39. Haddad, J., Vakulenko, S. B., and Mobashery, S. (1999). An antibiotic cloaked by its own resistance enzyme. J. Am. Chem. Soc. 121, 11922-11923.
40. Hall, R. M. (2012). Integrons and gene cassettes: hotspots of diversity in bacterial genomes. Ann. N.Y. Acad. Sci. 1267, 71-78.
41. Hancock, R. E. (1981). Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J. Antimicrob. Chemother. 8, 249-276.
42. Hermann, T. (2007). Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell. Mol. Life Sci. 64, 1841-1852.
43. Herzog, I. M., Green, K. D., Berkov-Zrihen, Y., Feldman, M., Vidavski, R. R., Eldar-Boock, A., et al. (2012). 6β-Thioether tobramycin analogues: towards selective targeting of bacterial membranes. Angew. Chem. Int. Ed. Engl. 51, 5652-5656.
44. Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., et al. (2003). MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 47, 1371-1375.
45. Houghton, J. L., Green, K. D., Chen, W., and Garneau-Tsodikova, S. (2010). The future of aminoglycosides: the end or renaissance? Chembiochem 11, 880-902.
46. Huon, L. K., Fang, T. Y., and Wang, P. C. (2012). Outcomes of intratympanic gentamicin injection to treat Meniere's disease. Otol. Neurotol. 33, 706-714.
47. Jana, S., and Deb, J. K. (2006). Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 70, 140-150.
48. Kandasamy, J., Atia-Glikin, D., Shulman, E., Shapira, K., Shavit, M., Belakhov, V., et al. (2012). Increased selectivity toward cytoplasmic versus mitochondrial ribosome confers improved efficiency of synthetic aminoglycosides in fixing damaged genes: a strategy for treatment of genetic diseases caused by nonsense mutations. J. Med. Chem. 55, 10630-10643.
49. Katoh, K., and Standley, D. (2013). MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772-780.
50. Kellermayer, R. (2006). Translational readthrough induction of pathogenic nonsense mutations. Eur. J. Med. Genet. 49, 445-450.
51. Kim, C., Villegas-Estrada, A., Hesek, D., and Mobashery, S. (2007). Mechanistic characterization of the bifunctional aminoglycoside-modifying enzyme AAC(3)-Ib/AAC(6β)-Ib' from Pseudomonas aeruginosa. Biochemistry 46, 5270-5282.
52. Kim, Y. T., Jang, J. H., Kim, H. C., Kim, H., Lee, K. R., Park, K. S., et al. (2011). Identification of strain harboring both aac(6β)-Ib and aac(6β)-Ib-cr variant simultaneously in Escherichia coli and Klebsiella pneumoniae. BMB Rep. 44, 262-266.
53. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., and Collins, J. J. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810.
54. Kondo, J., Hainrichson, M., Nudelman, I., Shallom-Shezifi, D., Barbieri, C. M., Pilch, D. S., et al. (2007). Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites. Chembiochem 8, 1700-1709.
55. Labaune, J. M., Bleyzac, N., Maire, P., Jelliffe, R. W., Boutroy, M. J., Aulagner, G., et al. (2001). Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models. Biol. Neonate 80, 142-147.
56. Lambert, T., Ploy, M. C., and Courvalin, P. (1994). A spontaneous point mutation in the aac(6β)-Ib' gene results in altered substrate specificity of aminoglycoside 6β-N-acetyltransferase of a Pseudomonas fluorescens strain. FEMS Microbiol. Lett. 115, 297-304.
57. Landman, D., Kelly, P., Backer, M., Babu, E., Shah, N., Bratu, S., et al. (2011). Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J. Antimicrob. Chemother. 66, 332-334.
58. Liu, M., Haddad, J., Azucena, E., Kotra, L. P., Kirzhner, M., and Mobashery, S. (2000). Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3β-phosphotransferases. J. Org. Chem. 65, 7422-7431.
59. Lombes, T., Begis, G., Maurice, F., Turcaud, S., Lecourt, T., Dardel, F., et al. (2008). NMR-guided fragment-based approach for the design of AAC(6β)-Ib ligands. Chembiochem 9, 1368-1371.
60. Lundblad, E. W., and Altman, S. (2010). Inhibition of gene expression by RNase P. N. Biotechnol. 27, 212-221.
61. Macleod, D. L., Nelson, L. E., Shawar, R. M., Lin, B. B., Lockwood, L. G., Dirk, J. E., et al. (2000). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J. Infect. Dis. 181, 1180-1184.
62. Magalhaes, M. L., Vetting, M. W., Gao, F., Freiburger, L., Auclair, K., and Blanchard, J. S. (2008). Kinetic and structural analysis of bisubstrate inhibition of the Salmonella enterica aminoglycoside 6β-N-acetyltransferase. Biochemistry 47, 579-584.
63. Magnet, S., and Blanchard, J. S. (2005). Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105, 477-498.
64. Magnet, S., Smith, T. A., Zheng, R., Nordmann, P., and Blanchard, J. S. (2003). Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase. Antimicrob. Agents Chemother. 47, 1577-1583.
65. Majumder, K., Wei, L., Annedi, S., and Kotra, L. P. (2007). "Aminoglycoside antibiotics," in Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, eds R. A. Bonomo and M. E. Tolmasky (Washington, DC: ASM Press), 7-20.
66. Maurice, F., Broutin, I., Podglajen, I., Benas, P., Collatz, E., and Dardel, F. (2008). Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep. 9, 344-349.
67. Mehta, R., and Champney, W. S. (2003). Neomycin and paromomycin inhibit 30S ribosomal subunit assembly in Staphylococcus aureus. Curr. Microbiol. 47, 237-243.
68. Mendes, R., Toleman, M., Ribeiro, J., Sader, H., Jones, R., and Walsh, T. (2004). Integron carrying a novel metallo-b-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistance gene aac(6β)-30/aac(6β)-Ib: report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 48, 4693-4702.
69. Menzies, D., Benedetti, A., Paydar, A., Martin, I., Royce, S., Pai, M., et al. (2009). Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 6:e1000146. doi: 10.1371/journal.pmed.1000146
70. Mikkelsen, N. E., Brannvall, M., Virtanen, A., and Kirsebom, L. A. (1999). Inhibition of RNase P RNA cleavage by aminoglycosides. Proc. Natl. Acad. Sci. U.S.A. 96, 6155-6160.
71. Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., et al. (1997). The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin. Infect. Dis. 24(Suppl. 1), S46-S62.
72. Morita, Y., Tomida, J., and Kawamura, Y. (2012). MexXY multidrug efflux system of Pseudomonas aeruginosa. Front. Microbiol. 3:408. doi: 10.3389/fmicb.2012.00408
73. Muir, M. E., Van Heeswyck, R. S., and Wallace, B. J. (1984). Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium. J. Gen. Microbiol. 130, 2015-2022.
74. Neuwald, A. F., and Landsman, D. (1997). GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. Trends Biochem. Sci. 22, 154-155.
75. O'Connor, M., De Stasio, E. A., and Dahlberg, A. E. (1991). Interaction between 16S ribosomal RNA and ribosomal protein S12: differential effects of paromomycin and streptomycin. Biochimie 73, 1493-1500.
76. Over, U., Gur, D., Unal, S., Miller, G. H., and Aminoglycoside Resistance Study Group. (2001). The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin. Microbiol. Infect. 7, 470-478.
77. Pacheu-Grau, D., Perez-Delgado, L., Gomez-Diaz, C., Fraile-Rodrigo, J., Montoya, J., and Ruiz-Pesini, E. (2012). Mitochondrial ribosome and Meniere's disease: a pilot study. Eur. Arch. Otorhinolaryngol. 269, 2003-2008.
78. Panaite, D. M., and Tolmasky, M. E. (1998). Characterization of mutants of the 6β-N-acetyltransferase encoded by the multiresistance transposon Tn1331: effect of Phen171-to-Leu171 and Tyr80-to-Cys80 substitutions. Plasmid 39, 123-133.
79. Poirel, L., Cabanne, L., Collet, L., and Nordmann, P. (2006). Class II transposon-borne structure harboring metallo-beta-lactamase gene blaVIM-2 in Pseudomonas putida. Antimicrob. Agents Chemother. 50, 2889-2891.
80. Pourreza, A., Witherspoon, M., Fox, J., Newmark, J., Bui, D., and Tolmasky, M. E. (2005). Mutagenesis analysis of a conserved region involved in acetyl coenzyme A binding in the aminoglycoside 6β-N-acetyltransferase type Ib encoded by plasmid pJHCMW1. Antimicrob. Agents Chemother. 49, 2979-2982.
81. Quiroga, M. P., Andres, P., Petroni, A., Soler Bistue, A. J., Guerriero, L., Vargas, L. J., et al. (2007). Complex class 1 integrons with diverse variable regions, including aac(6β)-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob. Agents Chemother. 51, 4466-4470.
82. Ramirez, M. S., Parenteau, T. R., Centron, D., and Tolmasky, M. E. (2008). Functional characterization of Tn1331 gene cassettes. J. Antimicrob. Chemother. 62, 669 -673.
83. Ramirez, M. S., and Tolmasky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151-171.
84. Rather, P. N., Munayyer, H., Mann, P. A., Hare, R. S., Miller, G. H., and Shaw, K. J. (1992). Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6β-N-acetyltransferase Ib and IIa proteins. J. Bacteriol. 174, 3196-3203.
85. Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197, 1079-1081.
86. Rice, L. B., Carias, L. L., Hutton, R. A., Rudin, S. D., Endimiani, A., and Bonomo, R. A. (2008). The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Anti-microb. Agents Chemother. 52, 3427-3429.
87. Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., et al. (1990). Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347, 358-363.
88. Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Park, C. H., et al. (2006). Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12, 83-88.
89. Rodriguez-Martinez, J. M., Cano, M. E., Velasco, C., Martinez-Martinez, L., and Pascual, A. (2011). Plasmid-mediated quinolone resistance: an update. J. Infect. Chemother. 17, 149-182.
90. Romanowska, J., Reuter, N., and Trylska, J. (2013). Comparing aminoglycoside binding sites in bacterial ribosomal RNA and aminoglycoside modifying enzymes. Proteins 81, 63-80.
91. Ruiz, J., Pons, M. J., and Gomes, C. (2012). Transferable mechanisms of quinolone resistance. Int. J. Antimicrob. Agents 40, 196-203.
92. Salipante, S. J., and Hall, B. G. (2003). Determining the limits of the evolutionary potential of an antibiotic resistance gene. Mol. Biol. Evol. 20, 653-659.
93. Sarno, R., Ha, H., Weinsetel, N., and Tolmasky, M. E. (2003). Inhibition of aminoglycoside 6β-N-acetyltransferase type Ib-mediated amikacin resistance by antisense oligodeoxynucleotides. Antimicrob. Agents Chemother. 47, 3296-3304.
94. Sarno, R., McGillivary, G., Sherratt, D. J., Actis, L. A., and Tolmasky, M. E. (2002). Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. Antimicrob. Agents Chemother. 46, 3422-3427.
95. Schmitt, E., Galimand, M., Panvert, M., Courvalin, P., and Mechulam, Y. (2009). Structural bases for 16 s rRNA methylation catalyzed by ArmA and RmtB methyltransferases. J. Mol. Biol. 388, 570-582.
96. Shaul, P., Green, K. D., Rutenberg, R., Kramer, M., Berkov-Zrihen, Y., Breiner-Goldstein, E., et al. (2011). Assessment of 6β-and 6β"-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance. Org. Biomol. Chem. 9, 4057-4063.
97. Shaw, K. J., Rather, P. N., Hare, R. S., and Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57, 138-163.
98. Shmara, A., Weinsetel, N., Dery, K. J., Chavideh, R., and Tolmasky, M. E. (2001). Systematic analysis of a conserved region of the aminoglycoside 6β-Nacetyltransferase type Ib. Antimicrob. Agents Chemother. 45, 3287-3292.
99. Sneath, P. H., and Sokal, R. R. (1973). Numerical Taxonomy. The Principles and Practice of Numerical Classification. San Francisco, CA: W. H. Freeman.
100. Soler Bistue, A. J., Birshan, D., Tomaras, A. P., Dandekar, M., Tran, T., Newmark, J., et al. (2008). Klebsiella pneumoniae multiresistance plasmid pMET1: similarity with the Yersinia pestis plasmid pCRY and integrative conjugative elements. PLoS ONE 3:e1800. doi: 10.1371/journal.pone.0001800
101. Soler Bistue, A. J., Ha, H., Sarno, R., Don, M., Zorreguieta, A., and Tolmasky, M. E. (2007). External guide sequences targeting the aac(6β)-Ib mRNA induce inhibition of amikacin resistance. Antimicrob. Agents Chemother. 51, 1918-1925.
102. Soler Bistue, A. J., Martin, F. A., Petroni, A., Faccone, D., Galas, M., Tolmasky, M. E., et al. (2006). Vibrio cholerae InV117, a class 1 integron harboring aac(6β)-Ib and blaCTX-M-2, is linked to transposition genes. Antimicrob. Agents Chemother. 50, 1903-1907.
103. Soler Bistue, A. J., Martin, F. A., Vozza, N., Ha, H., Joaquin, J. C., Zorreguieta, A., et al. (2009). Inhibition of aac(6β)-Ib-mediated amikacin resistance by nucleaseresistant external guide sequences in bacteria. Proc. Natl. Acad. Sci. U.S.A. 106, 13230-13235.
104. Strahilevitz, J., Jacoby, G. A., Hooper, D. C., and Robicsek, A. (2009). Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22, 664-689.
105. Taber, H. W., Mueller, J. P., Miller, P. F., and Arrow, A. S. (1987). Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51, 439-457.
106. Tolmasky, M. (2007a). "Aminogylcoside-modifying enzymes: characteristics, localization, and dissemination," in Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, eds R. Bonomo and M. Tolmasky (Washington, DC: ASM Press), 35-52.
107. Tolmasky, M. E. (2007b). "Overview of dissemination mechanisms of genes coding for resistance to antibiotics," in Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, eds R. Bonomo and M. E. Tolmasky (Washington, DC: ASM Press), 267-270.
108. Tolmasky, M. E. (1990). Sequencing and expression of aadA, bla, and tnpR from the multiresistance transposon Tn1331. Plasmid 24, 218-226.
109. Tolmasky, M. E., Chamorro, R. M., Crosa, J. H., and Marini, P. M. (1988). Transposon-mediated amikacin resistance in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 32, 1416-1420.
110. Tolmasky, M. E., and Crosa, J. H. (1987). Tn1331, a novel multiresistance transposon encoding resistance to amikacin and ampicillin in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 31, 1955-1960.
111. Tolmasky, M. E., and Crosa, J. H. (1991). Regulation of plasmid-mediated iron transport and virulence in Vibrio anguillarum. Biol. Met. 4, 33-35.
112. Tolmasky, M. E., and Crosa, J. H. (1993). Genetic organization of antibiotic resistance genes (aac(6β)-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. Plasmid 29, 31-40.
113. Traglia, G., Davies Sala, C., Fuxman Bass, J., Soler Bistué, A., Zorreguieta, A., Ramirez, M. S., et al. (2012). Internalization of locked nucleic acids/DNA hybrid oligomers into Escherichia coli. Biores. Open Access 1, 260-263.
114. Vakulenko, S. B., and Mobashery, S. (2003). Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16, 430-450.
115. Van 't Veen, A., Van Der Zee, A., Nelson, J., Speelberg, B., Kluytmans, J. A., and Buiting, A. G. (2005). Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms. J. Clin. Microbiol. 43, 4961-4967.
116. Vetting, M. W., Lp, S. D. C., Yu, M., Hegde, S. S., Magnet, S., Roderick, S. L., et al. (2005). Structure and functions of the GNAT superfamily of acetyltransferases. Arch. Biochem. Biophys. 433, 212-226.
117. Vetting, M. W., Magnet, S., Nieves, E., Roderick, S. L., and Blanchard, J. S. (2004). A bacterial acetyltransferase capable of regioselective N-acetylation of antibiotics and histones. Chem. Biol. 11, 565-573.
118. Vetting, M. W., Park, C. H., Hegde, S. S., Jacoby, G. A., Hooper, D. C., and Blanchard, J. S. (2008). Mechanistic and structural analysis of aminoglycoside Nacetyltransferase AAC(6β)-Ib and its bifunctional, fluoroquinolone-active AAC(6β)-Ib-cr variant. Biochemistry 47, 9825-9835.
119. Vicens, Q., and Westhof, E. (2003). Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures. Biopolymers 70, 42-57.
120. Villa, L., Poirel, L., Nordmann, P., Carta, C., and Carattoli, A. (2012). Complete sequencing of an IncH plasmid carrying the blaNDM-1, blaCTX-M-15 and qnrB1 genes. J. Antimicrob. Chemother. 67, 1645-1650.
121. Vong, K., Tam, I. S., Yan, X., and Auclair, K. (2012). Inhibitors of aminoglycoside resistance activated in cells. ACS Chem. Biol. 7, 470-475.
122. Wachino, J., and Arakawa, Y. (2012). Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update. Drug Resist. Updat. 15, 133-148.
123. Warburg, G., Hidalgo-Grass, C., Partridge, S. R., Tolmasky, M. E., Temper, V., Moses, A. E., et al. (2012). A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6β)-Ib. J. Antimicrob. Chemother. 67, 898-901.
124. Welch, K. T., Virga, K. G., Whittemore, N. A., Ozen, C., Wright, E., Brown, C. L., et al. (2005). Discovery of non-carbohydrate inhibitors of aminoglycoside-modifying enzymes. Bioorg. Med. Chem. 13, 6252-6263.
125. Williams, J. W., and Northrop, D. B. (1979). Synthesis of a tight-binding, multisubstrate analog inhibitor of gentamicin acetyltransferase I. J. Antibiot. 32, 1147-1154.
126. Woloj, M., Tolmasky, M. E., Roberts, M. C., and Crosa, J. H. (1986). Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis. Antimicrob. Agents Chemother. 29, 315-319.
127. Woodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., and Livermore, D. M. (2009). Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53, 4472-4482.
128. Wright, G. D. (1999). Aminoglycoside-modifying enzymes. Curr. Opin. Microbiol. 2, 499-503.
129. Wright, G. D., and Berghuis, A. M. (2007). "Structural aspects of aminoglycoside modifying enzymes," in Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, eds R. Bonomo and M. Tolmasky (Washington, DC: ASM Press), 21-33.
130. Wright, G. D., and Ladak, P. (1997). Overexpression and characterization of the chromosomal aminoglycoside 6β-N-acetyltransferase from Enterococcus faecium. Antimicrob. Agents Chemother. 41, 956-960.
131. Wybenga-Groot, L. E., Draker, K., Wright, G. D., and Berghuis, A. M. (1999). Crystal structure of an aminoglycoside 6β-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold. Structure 7, 497-507.
132. Yao, J., and Moellering, R. (2007). "Antibacterial agents," in Manual of Clinical Microbiology, eds P. Murray, E. Baron, J. Jorgensen, M. Landry, and M. Pfaller (Washington, DC: American Society for Microbiology Press), 1077-1113.
133. Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., et al. (2009). Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046-5054.
134. Zaher, H. S., and Green, R. (2009). Fidelity at the molecular level: lessons from protein synthesis. Cell 136, 746-762.
135. Zingman, L. V., Park, S., Olson, T. M., Alekseev, A. E., and Terzic, A. (2007). Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin. Pharmacol. Ther. 81, 99-103.
136. Zong, Z., Partridge, S. R., and Iredell, J. R. (2009). A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure. Antimicrob. Agents Chemother. 53, 1693-1697.